Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR1204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WISP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RXRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC51145 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRICKLE2-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927438 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on